Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INSPIRE MEDICAL SYSTEMS, INC.

(INSP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 9831 7375 0666 542--
Entreprise Value (EV)1 8201 7374 8576 4126 4306 411
P/E ratio -28,2x-53,0x-85,9x-110x-142x-288x
Yield ------
Capitalization / Revenue 19,4x21,2x43,9x30,7x22,6x17,6x
EV / Revenue 16,2x21,2x42,1x30,1x22,3x17,2x
EV / EBITDA -41,0x-61,6x-114x-129x-177x3 826x
Price to Book -12,8x21,3x34,3x48,0x60,0x
Nbr of stocks (in thousands) 23 27523 40226 93527 272--
Reference price (USD) 42,374,2188240240240
Announcement Date 02/26/201902/25/202002/23/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 50,682,1115213289373
EBITDA1 -20,0-28,2-42,6-49,7-36,41,68
Operating profit (EBIT)1 -20,4-34,9-56,2-59,7-46,0-19,6
Operating Margin -40,3%-42,5%-48,7%-28,0%-15,9%-5,27%
Pre-Tax Profit (EBT)1 -21,8-33,2-57,1-60,1-47,3-23,2
Net income1 -21,8-33,2-57,2-59,7-47,2-24,0
Net margin -43,1%-40,5%-49,6%-28,0%-16,3%-6,43%
EPS2 -1,50-1,40-2,19-2,19-1,69-0,83
Dividend per Share2 ------
Announcement Date 02/26/201902/25/202002/23/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 46,040,453,055,763,158,3
EBITDA1 -2,96-9,46-5,90-12,4-11,7-15,7
Operating profit (EBIT)1 -7,06-15,7-12,5-16,8-16,0-16,0
Operating Margin -15,3%-38,9%-23,7%-30,1%-25,4%-27,5%
Pre-Tax Profit (EBT)1 -7,46-16,2-13,1-16,2-16,3-17,1
Net income1 -7,48-16,2-13,1-16,0-15,7-17,3
Net margin -16,3%-40,2%-24,7%-28,8%-24,9%-29,7%
EPS2 -0,28-0,60-0,48-0,58-0,55-0,66
Dividend per Share ------
Announcement Date 02/23/202105/04/202108/03/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 163-210130112130
Leverage (Debt / EBITDA) 8,17x-4,93x2,62x3,07x-77,9x
Free Cash Flow1 -18,9-35,6-55,5-59,7-28,76,33
ROE (Net Profit / Equities) -26,4%-21,9%-31,0%-30,1%-38,1%-18,3%
Shareholders' equity1 82,7152185199124131
ROA (Net Profit / Asset) ---24,7%-26,0%-28,8%-17,5%
Assets1 --231230164137
Book Value Per Share2 -5,808,817,005,004,00
Cash Flow per Share2 -1,28-1,38-2,03-1,68-1,03-
Capex1 0,252,742,465,335,336,67
Capex / Sales 0,49%3,34%2,13%2,50%1,85%1,79%
Announcement Date 02/26/201902/25/202002/23/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 6 541 910 928
Net sales (USD) 115 381 000
Number of employees 341
Sales / Employee (USD) 338 361
Free-Float 97,2%
Free-Float capitalization (USD) 6 355 596 132
Avg. Exchange 20 sessions (USD) 52 762 033
Average Daily Capital Traded 0,81%
EPS & Dividend